Description：

Taselisib (GDC 0032) is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with K_i of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.

Chemical Information：

Molecular Weight (MW)		460.53
Formula		C24H28N8O2
CAS No.		1282512-48-4
Solubility (25°C) *	DMSO	70 mg/mL warmed (151.99 mM)
	Water	Insoluble
	Alcohol	Insoluble warmed

Preparing Stock Solutions

Concentration Volume (DMSO) Mass	1 mg	5 mg	10 mg
1 mM	2.1714 mL	10.8571 mL	21.7141 mL
5 mM	0.4343 mL	2.1714 mL	4.3428 mL
10 mM	0.2171 mL	1.0857 mL	2.1714 mL
50 mM	0.0434 mL	0.2171 mL	0.4343 mL

Bought notes(bought amounts latest0)

No one bought this product

Total 0 records, divided into1 pages. First Prev Next Last